A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

NCT00857857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GW870086X
DRUG: FP
DRUG: Placebo

Sponsor

GlaxoSmithKline